Salpingo-Oophorectomy Procedure
Description, Latest Information and Doctors

Salpingo-Oophorectomy Overview

Save information for later
Sign Up

Learn About Salpingo-Oophorectomy

Who are the top Salpingo-Oophorectomy Local Doctors?
Elite in Salpingo-Oophorectomy
Elite in Salpingo-Oophorectomy
Referral may be required
790 Bay Street, 
Toronto, ON, CA 

Steven Narod practices practicing medicine in Toronto, Canada. Mr. Narod is rated as an Elite expert by MediFind in Oophorectomy. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Breast Cancer, BRCA Positive Breast Cancer, Oophorectomy, and Mastectomy.

Elite in Salpingo-Oophorectomy
Elite in Salpingo-Oophorectomy
Referral may be required
76 Grenville St, 
Toronto, ON, CA 

Joanne Kotsopoulos practices practicing medicine in Toronto, Canada. Ms. Kotsopoulos is rated as an Elite expert by MediFind in Oophorectomy. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, BRCA Positive Breast Cancer, Breast Cancer, Oophorectomy, and Salpingo-Oophorectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Salpingo-Oophorectomy
Elite in Salpingo-Oophorectomy
Referral may be required
Montreal, QC, CA 

William Foulkes practices practicing medicine in Montreal, Canada. Mr. Foulkes is rated as an Elite expert by MediFind in Oophorectomy. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Sertoli-Leydig Cell Tumor, Ovarian Cancer, DICER1 Syndrome, Oophorectomy, and Mastectomy.

View All Doctors
What are the latest Salpingo-Oophorectomy Clinical Trials?
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)
Enrollment Status: Recruiting
Publish Date: September 02, 2026
Intervention Type: Drug
Study Phase: Phase 3

Summary: This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
Enrollment Status: Recruiting
Publish Date: August 07, 2026
Intervention Type: Other, Procedure
Study Phase: Not Applicable

Summary: This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study m...

View All Clinical Trials